KRISTEN DINKEL: Open Payments
NPI 1144716242 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 23 payments from 8 companies in 2025. Trend: 2023 $118 · 2024 $443 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $158 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| PFIZER INC. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Wegovy, LEQVIO, VYNDAQEL, LifeVest, CAMZYOS, ELIQUIS, JARDIANCE, Attruby.
Industry payments across KS — which companies pay providers there.
